Enovis Corp. (ENOV)
18.56
-0.84
(-4.33%)
USD |
NYSE |
Sep 04, 16:00
18.66
+0.10
(+0.54%)
Pre-Market: 20:00
Enovis Research and Development Expense (Quarterly) : 31.69M for June 30, 2026
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Research and Development Expense (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 31.69M |
| March 31, 2026 | 31.53M |
| December 31, 2025 | 31.36M |
| September 30, 2025 | 29.74M |
| June 30, 2025 | 30.70M |
| March 31, 2025 | 28.53M |
| December 31, 2024 | 23.95M |
| September 30, 2024 | 20.49M |
| June 30, 2024 | 23.48M |
| March 31, 2024 | 23.38M |
| December 31, 2023 | 18.32M |
| September 30, 2023 | 19.90M |
| June 30, 2023 | 18.92M |
| March 31, 2023 | 18.19M |
| December 31, 2022 | 14.72M |
| September 30, 2022 | 15.60M |
| June 30, 2022 | 15.66M |
| March 31, 2022 | 14.84M |
| December 31, 2021 | 15.23M |
| September 30, 2021 | 12.46M |
| June 30, 2021 | 11.04M |
| March 31, 2021 | 19.90M |
| December 31, 2020 | 19.20M |
| September 30, 2020 | 16.80M |
| June 30, 2020 |
| Date | Value |
|---|---|
| March 31, 2020 | |
| December 31, 2019 | |
| September 30, 2019 | |
| June 30, 2019 | |
| March 31, 2019 | |
| December 31, 2018 | |
| September 30, 2018 | |
| June 30, 2018 | |
| March 31, 2018 | |
| December 31, 2017 | |
| September 30, 2017 | |
| June 30, 2017 | |
| March 31, 2017 | |
| December 31, 2016 | |
| September 30, 2016 | |
| June 30, 2016 | |
| March 31, 2016 | |
| December 31, 2015 | |
| September 30, 2015 | |
| June 30, 2015 | |
| March 31, 2015 | |
| December 31, 2014 | |
| September 30, 2014 | |
| June 30, 2014 | |
| March 31, 2014 |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Intuitive Surgical, Inc. | 370.40M |
| STAAR Surgical Co. | 9.769M |
| Inspire Medical Systems, Inc. | 24.70M |
| Edwards Lifesciences Corp. | 278.90M |
| Kewaunee Scientific Corp. | -- |